Member Publications

• Associations of nutrition impact symptoms with dietary intake and eating-related distress in patients with advanced cancer

Amano K et al. Clinical Nutrition ESPEN (2024). 

• Associations of nutrition impact symptoms with depression in patients with advanced cancer

Amano K et al. Supportive Care in Cancer (2024). 

• The rise of supportive oncology: A revolution in cancer care

Berman R et al. Clinical Oncology (2023). 

• Mucositis and infection in hematology patients

Blijlevens MA & de Mooij CEM. International Journal of Molecular Sciences (2023). 

• Development of an international competency framework for nurses in the provision of self-management support to cancer populations

Chan RJ et al. Cancer Nursing (2022).

• Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature

Chan RJ et al. CA: A Cancer Journal for Clinicians (2023).

• Ten top tips for research grant writing: A guide for oncology nurses and allied health professionals

Chan RJ & Hart NH. Seminars in Oncology Nursing (2023).

• Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: A national cohort study

Christensen SK et al. Supportive Care in Cancer (2024). 

• What lurks beneath the symptom? Why more basic scientists are needed in cancer supportive care and survivorship research

Cross CB et al. Supportive Care in Cancer (2024).

• Reproductive choice is supportive care in cancer

Dixit N et al. Supportive Care in Cancer (2023).

• Ponsegromab for the treatment of cancer cachexia

Groarke JD et al. The New England Journal of Medicine (2024). 

• Cancer survivorship in the Indo-Pacific: Priorities for progress

Koczwara B et al. JCO Global Oncology (2023).

• Sex-related differences in eating-related distress experienced by patients with advanced cancer

Koshimoto S et al. Supportive Care in Cancer (2025). 

• Incidence and mitigation of corneal pseudomicrocysts induced by antibody-drug conjugates (ADCs)

Lindgren ES et al. Current Ophthalmology Reports (2024). 

• The right dose: Results of a patient advocate-led survey of individuals with metastatic breast cancer regarding treatment-related side effects and views about dosage assessment to optimize quality of life

Loeser A et al. JCO Oncology Practice (2024). 

• Effective strategies for the prevention and mitigation of phosphatidylinositol-3-kinase inhibitor-associated hyperglycemia: Optimizing patient care

Moore HN et al. Clinical Breast Cancer (2025)

• Olanzapine as antiemetic prophylaxis in moderately emetogenic chemotherapy: A phase 3 randomized clinical trial

Ostwal V et al. JAMA Network (2024). 

• A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer

Rodón J et al. Breast Cancer Research (2024). 

• Patient and caregiver education to support self-efficacy and self-management during immunotherapy – an integrative review

Rothausen CS et al. Psychooncology (2025). 

• Local sociocultural practice specific financial toxicity assessment tool for cancer: An emerging need

Sharma P et al. JCO Global Oncology (2024). 

• Enhancing patient outcomes through integrated education and navigation programs at the Breast Cancer Comprehensive Center, National Cancer Institute, Cairo University

Shash E et al. Journal of Cancer Education (2024).

• Low-risk febrile neutropenia: Does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach?

Weaver JMJ et al. Supportive Care in Cancer (2025).  

• Frequency and characteristics of advanced cancer patients with COVID + ve status among inpatient supportive care consults during the pandemic: Experience from a tertiary cancer center.

Yennurajalingam S et al. Supportive Care in Cancer (2022).